Literature DB >> 6803569

Hypothesis: leukocyte endogenous mediator/endogenous pyrogen/lymphocyte-activating factor modulates the development of nonspecific and specific immunity and affects nutritional status.

M C Powanda, W R Beisel.   

Abstract

We postulate that leukocyte endogenous mediator/endogenous pyrogen/lymphocyte-activating factor (LEM/EP/LAF) integrates the host's nonspecific and specific immune responses to infection by virtue of the panoply of physiological and metabolic activities it is capable of eliciting. The alterations in systemic metabolism modulated by LEM/EP/LAF, although apparently of value to the host in the defense against infection and the repair of tissue damage, result in negative nutrient balances. Severe infections, alone or in conjunction with injury, may result in malnutrition unless the patient is adequately nourished. Preexisting nutritional deficits can compromise host resistance to infection, in part by preventing production of LEM/EP/LAF. Additional studies of the sequelae of LEM/EP/LAF action and effects of nutrition on host resistance to infection appear warranted.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6803569     DOI: 10.1093/ajcn/35.4.762

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  11 in total

1.  Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum.

Authors:  L C Gahring; A Buckley; R A Daynes
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

2.  Effects of continuously administered murine interleukin-1 alpha: tolerance development and granuloma formation.

Authors:  I G Otterness; H W Golden; W H Brissette; P A Seymour; G O Daumy
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

3.  Early plasma protein and mineral changes after surgery: a two stage process.

Authors:  M A Myers; A Fleck; B Sampson; C M Colley; J Bent; G Hall
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

4.  The metabolic response to trauma and sepsis.

Authors:  J Hassett; J R Border
Journal:  World J Surg       Date:  1983-01       Impact factor: 3.352

5.  Neuropeptide regulation of interleukin-1 activities. Capacity of alpha-melanocyte stimulating hormone to inhibit interleukin-1-inducible responses in vivo and in vitro exhibits target cell selectivity.

Authors:  B A Robertson; L C Gahring; R A Daynes
Journal:  Inflammation       Date:  1986-12       Impact factor: 4.092

Review 6.  Total parenteral nutrition 1990. A review of its current status in hospitalised patients, and the need for patient-specific feeding.

Authors:  D F Driscoll; G L Blackburn
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

7.  Nutritional status in patients with rheumatoid arthritis.

Authors:  M Helliwell; E J Coombes; B J Moody; G F Batstone; J C Robertson
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

8.  Effect of ibuprofen on fever and metabolic changes induced by continuous infusion of leukocytic pyrogen (interleukin 1) or endotoxin.

Authors:  J Sobrado; L L Moldawer; B R Bistrian; C A Dinarello; G L Blackburn
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

9.  Blunt multiple trauma (ISS 36), femur traction, and the pulmonary failure-septic state.

Authors:  R Seibel; J LaDuca; J M Hassett; G Babikian; B Mills; D O Border; J R Border
Journal:  Ann Surg       Date:  1985-09       Impact factor: 12.969

10.  Survival from sepsis. The significance of altered protein metabolism regulated by proteolysis inducing factor, the circulating cleavage product of interleukin-1.

Authors:  G H Clowes; E Hirsch; B C George; L M Bigatello; J E Mazuski; C A Villee
Journal:  Ann Surg       Date:  1985-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.